GRAND RAPIDS – MichBio, the association for Michigan’s bioscience industry, announced that Kim Popovits, president and CEO of Genomic Health, Inc. will keynote the 2011 MichBio Expo & Conference. The MichBio Expo & Conference is Michigan’s largest gathering of bioscience-related professionals. It is set for November 2-3 at DeVos Place in Grand Rapids.
?We?re excited to have someone as distinguished as Kim Popovits for our 2011 keynote speaker. She is an industry thought leader on personalized medicine, and Genomic Health is a game-changing innovator in the field, with special emphasis on oncology,? said Stephen Rapundalo, Ph.D., MichBio president and CEO. ?Personalized treatment of patients through predictive molecular diagnostics is here now, and Kim and Genomic Health are at the forefront of this healthcare revolution.?
Genomic Health is a molecular diagnostics company focused on the global development and commercialization of genomic-based clinical laboratory services that analyze the underlying biology of cancer allowing physicians and patients to make individualized treatment decisions.
Popovits has served as president and CEO of Genomic Health since January 2009 and as president and COO since January 2002. From November 1987 to February 2002, she served in various roles at Genentech, Inc., a biotechnology company, most recently as senior vice president, Marketing and Sales, from February 2001 to February 2002, and as vice president, Sales, from October 1994 to February 2001. Prior to joining Genentech in November 1987, she was division manager for American Critical Care, a Division of American Hospital Supply. Popovits holds a B.A. degree in Business from Michigan State University.
?The 2010 MichBio Expo & Conference is shaping up to be an outstanding event, and we are delighted to bring the event back to the Grand Rapids area, where this burgeoning bioscience hub has witnessed significant expansion in recent years,? said Rapundalo. ?In addition to our keynote speaker, the Expo features, our Fifth Annual Emerging Biosciences Showcase of start-up companies seeking investment funding, facility tours of area bioscience companies, manufacturing sessions, policy summit, exhibits, and track sessions in pharma, medical devices, ag/bio-based technologies and emerging business. It is a dynamic opportunity for networking, education and business development, and not to be missed.?
a>>
